Market Value1,220,168,000
Total Holdings55
File Date2015-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GWP / GW Pharmaceuticals plc
/ Achaogen Inc
NUVA / Nuvasive Inc
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
MODN / Model N, Inc.
CERS / Cerus Corporation
SIOX / Sio Gene Therapies Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
ABUS / Arbutus Biopharma Corporation
91911K102 / Bausch Health Companies
AET / Aetna, Inc.
NSTG / NanoString Technologies, Inc.
PRQR / ProQR Therapeutics N.V.
ENDP / Endo International plc
RCPT / Receptos, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
SESN / Sesen Bio Inc.
RARE / Ultragenyx Pharmaceutical Inc.
MARKET VECTORS ETF TR / PHARMACEUTICAL (57060U217)
ITCI / Intra-Cellular Therapies, Inc.
0PP / Portola Pharmaceuticals Inc
IHF / iShares Trust - iShares U.S. Healthcare Providers ETF
/ Oxford Immunotec Global PLC
ABBV / AbbVie Inc.
QQQ / Invesco QQQ Trust, Series 1
FLXN / Horizon Funds - Horizon Flexible Income ETF
TRIV / TriVascular Technologies, Inc.
KYTH / Kythera Biopharma
OTIC / Otonomy Inc
BLCM / Bellicum Pharmaceuticals, Inc.
TVTY / Tivity Health Inc
HNT / Health Net Inc.
GNCA / Genocea Biosciences Inc
CASC / Cascadian Therapeutics, Inc.
01449J105 / Alere Inc.
918194101 / VCA Inc.
CIVI / Civitas Resources, Inc.
BIOS / BioPlus Acquisition Corp - Class A
KDNY / Chinook Therapeutics Inc
GMED / Globus Medical, Inc.
CSLT / Castlight Health Inc - Class B
ADVM / Adverum Biotechnologies, Inc.
ZSPH / ZS Pharma, Inc.
ASPX / Auspex Pharmaceuticals, Inc.
BIIB / Biogen Inc.
INCY / Incyte Corporation
CCXI / ChemoCentryx Inc
UHS / Universal Health Services, Inc.
SGEN / Seagen Inc
018490100 / Allergan plc
DVA / DaVita Inc.
CMRX / Chimerix, Inc.
/ Array BioPharma, Inc.
BMRN / BioMarin Pharmaceutical Inc.
HCA / HCA Healthcare, Inc.
NVTA / Invitae Corporation
INSM / Insmed Incorporated
ARAY / Accuray Incorporated
BPMC / Blueprint Medicines Corporation
SAGE / Sage Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
CLVS / Clovis Oncology Inc
CLDX / Celldex Therapeutics, Inc.
CI / The Cigna Group
LAB / Standard BioTools Inc.
ATRA / Atara Biotherapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.